An umbrella review concluded that fecal microbiota transplantation may aid short-term ulcerative colitis remission, but extensive overlap across published systematic reviews likely inflates the perceived strength of the trial evidence. The analysis highlights how review duplication can distort confidence levels and complicate decision-making. For clinicians and sponsors, the takeaway is caution: evidence signals exist, yet the quality and interpretability of the accumulated review literature may be weaker than it appears. The findings may influence how future trials and guideline updates weigh FMT benefit versus uncertainty.